Temozolomide and irinotecan regimen as liquid biopsy-guided non-cross reistant sequential adjuvant treatment of patients with MGMT methylated, micro satellite stable colorectal cancer failing to achieve seroreversion after a standard adjuvant strategy (Studio ERAZE-TMZ)
Tipologia: Collaborazione Professionale
Stato: Chiuso
Data Emissione:
Data Scadenza:
Ultimo aggiornamento: 22/09/2025
